# Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia

> **NCT00002719** · PHASE3 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 500 (estimated)

## Conditions studied

- Leukemia
- Neutropenia

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** amsacrine
- **DRUG:** carmustine
- **DRUG:** cytarabine
- **DRUG:** etoposide
- **DRUG:** idarubicin
- **DRUG:** mitoxantrone hydrochloride
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00002719
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-12
- **Primary completion:** 2001-11
- **Final completion:** —
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2012-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002719, "Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*